Causes for Hospitalization and Death in Iranian Patients with β-Thalassemia Major
- 26 August 2010
- journal article
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 28 (2) , 134-139
Abstract
There are limited studies that have focused on the causes for hospitalization as an indicator of morbidity in patients with β-thalassemia major (BTM). A cross-sectional study was conducted to determine the main causes for hospitalization and death in hospitalized BTM patients in a referral hospital in Shiraz, southern Iran. During a 5-year period, 555 BTM patients were admitted to the hospital, of which 390 (67.7%) were 10 to 20 years of age. The most frequent causes for hospitalization were splenectomy (23%), heart failure (22.6%), liver biopsy (22.2%), uncontrolled diabetes (10.9%), arrhythmia (7.2%), cholecystectomy (3.8%), hypoparathyroidism (2.1%), and sepsis (2%). Of the hospitalized patients, 65 (11%), with a mean age of 16.1 ± 4.2 years, died. The most common causes of death were cardiomyopathy (72.3%), infections (17%), malignancies (3.1%), and cerebrovascular accidents (3.1%). Survival of our patients was less than in developed countries and cardiac complications were the most common cause of mortality and morbidity in these patients. Regarding the key role of iron chelation in prevention of different complications in BTM, correction of iron chelation regimen should be well considered.Keywords
This publication has 17 references indexed in Scilit:
- ENDOCRINOPATHIES IN PATIENTS WITH TRANSFUSION-DEPENDENT ß-THALASSEMIAPediatric Hematology and Oncology, 2008
- Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi‐center study of iron overloadAmerican Journal of Hematology, 2007
- Apolipoprotein E gene polymorphism and left ventricular function in Iranian patients with thalassemia majorHaematologica, 2007
- Survival of Thalassemic Patients Referred to the Boo Ali Sina Teaching Hospital, Sari, IranHemoglobin, 2007
- Severe infections in thalassaemic patients: prevalence and predisposing factorsBritish Journal of Haematology, 2006
- Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia majorBlood, 2006
- Cardiac status in well‐treated patients with thalassemia majorEuropean Journal of Haematology, 2004
- Endocrine Gland Abnormalities in Thalassemia Major: Λ Brief ReviewJournal of Pediatric Endocrinology and Metabolism, 2003
- Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overloadEuropean Heart Journal, 2001
- Heart failure in beta thalassemia: a 5-year follow-up studyThe American Journal of Medicine, 2001